Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

SeaStar Medical Holding (ICU) EBIT (2023 - 2025)

Historic EBIT for SeaStar Medical Holding (ICU) over the last 3 years, with Q3 2025 value amounting to -$3.6 million.

  • SeaStar Medical Holding's EBIT rose 1968.13% to -$3.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$13.9 million, marking a year-over-year increase of 1304.02%. This contributed to the annual value of -$17.8 million for FY2024, which is 2555.95% down from last year.
  • Per SeaStar Medical Holding's latest filing, its EBIT stood at -$3.6 million for Q3 2025, which was up 1968.13% from -$1.8 million recorded in Q2 2025.
  • Over the past 5 years, SeaStar Medical Holding's EBIT peaked at -$1.8 million during Q2 2025, and registered a low of -$4.8 million during Q4 2024.
  • Its 3-year average for EBIT is -$3.7 million, with a median of -$3.8 million in 2025.
  • Its EBIT has fluctuated over the past 5 years, first tumbled by 6230.85% in 2024, then soared by 6239.02% in 2025.
  • Quarter analysis of 3 years shows SeaStar Medical Holding's EBIT stood at -$2.9 million in 2023, then crashed by 62.31% to -$4.8 million in 2024, then grew by 24.92% to -$3.6 million in 2025.
  • Its EBIT was -$3.6 million in Q3 2025, compared to -$1.8 million in Q2 2025 and -$3.8 million in Q1 2025.